News - UF Innovate

Neobiosis Appoints Pascal Goldschmidt, M.D. as Chief Medical Officer

UF Innovate | Sid Martin Biotech resident Neobiosis, a clinical-stage contract development and manufacturing organization, managed by scientists and physicians and focused on the science of regenerative medicine, announced the appointment of Pascal Goldschmidt, M.D. as Chief Medical Officer.

New Process May Help Regenerate Damaged Human Hearts

A groundbreaking new study by UF Innovate | Sid Martin Biotech resident Neobiosis may speed up the effort to defeat heart disease.

Over 60? Stop Doing This ASAP, Say Experts

Nineteen ways to live a healthy life after 60.

Scientists Help Watermelon Growers Nip Disease in the Bud

As people around the nation enjoy slices of cool watermelon this Memorial Day weekend, they can thank a dedicated network of Florida growers and UF...

UF Scientists Rate Effectiveness of COVID-19 Vaccines

Most coronavirus vaccines protect against death from disease, University of Florida scientists said. Research shows that Pfizer / BioNTech and Moderna are the most effective vaccines.

VetGuardian a Finalist in VMX 2021 Pet Pitch Competition

UF startup VetGuardian was among five finalists chosen by the North American Veterinary Community for its fourth annual VMX Pet Pitch Competition.

Resilience To Get $164M for Site Expansion

Resilience, a manufacturing and technology company that recently acquired Ology Bioservices, will receive $164M to update and expand a site in Ontario.

AGTC Breaks Ground on New Biotech Lab in Alachua

Applied Genetic Technologies Corporation will build a new 21,000 square foot laboratory facility in Alachua. The facility will include control labs and a manufacturing suite and will add 50 jobs.

AI Technique Reveals Dysfunctional Gut Microbiome Bacteria’s Role in Depression and High Blood Pressure

To solve the elusive medical mystery of why many adults have both high blood pressure and depression, University of Florida Health researchers took a long, in-depth look at one suspected culprit: gut bacteria.

UF Neuroscience Expert Dr. Eduardo Candelario-Jalil Appointed on Emerald Health Pharmaceuticals Scientific Advisory Board

Emerald Health Pharmaceuticals Inc., a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet medical needs, has expanded its Scientific Advisory Board with the appointment of University of Florida's neuroscience expert and innovator, Eduardo Candelario-Jalil, Ph.D.

UF News